XML 23 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Marketable Securities
9 Months Ended
Sep. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Marketable Securities 
The Company has investments in available-for-sale marketable securities which are recorded at fair market value. Prior to January 1, 2018, unrealized gains and losses on all securities are recorded as other comprehensive income (loss) in shareholders’ equity, net of income tax effects.
On January 1, 2018, the Company adopted ASU 2016-01, which requires the change in the fair value of available-for-sale equity investments to be recognized in our condensed consolidated statements of income (loss) rather than as a component of our condensed consolidated statement of comprehensive income (loss). For the three and nine months ended September 30, 2018, the net unrealized gain (loss) on our available-for-sale equity investments, recorded as a component of investment income in the accompanying condensed consolidated statements of income (loss), was immaterial. For comparability purposes, the net unrealized loss on our available-for-sale equity investments was $878 for the three months ended September 30, 2017 and the net unrealized gain was immaterial for the nine months ended September 30, 2017. These amounts were recorded as other comprehensive income in shareholders’ equity, net of income tax effects for the three and nine months ended September 30, 2017.
The following tables show the Company’s available-for-sale securities’ adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of September 30, 2018 and December 31, 2017, respectively:
 
 
September 30, 2018
Marketable Securities:
 
Adjusted Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value
 
 
 
 
 
 
 
 
 
Equity securities
 
$
10,068

 
$
77

 
$
(209
)
 
$
9,936

Money market funds
 
41,350

 
200

 

 
41,550

Corporate bonds
 
33,266

 
6

 
(236
)
 
33,036

Government securities - U.S.
 
13,756

 

 
(200
)
 
13,556

Other fixed-income securities
 
9,361

 
9

 
(23
)
 
9,347

Total
 
$
107,801

 
$
292

 
$
(668
)
 
$
107,425

 
 
December 31, 2017
Marketable Securities:
 
Adjusted Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value
 
 
 
 
 
 
 
 
 
Equity securities
 
$
443

 
$
31

 
$
(6
)
 
$
468

Money market funds
 
44,525

 

 
(44
)
 
44,481

Corporate bonds
 
9,285

 
1

 
(24
)
 
9,262

Government securities - U.S.
 
19,080

 

 
(30
)
 
19,050

Other fixed-income securities
 
4,259

 

 
(9
)
 
4,250

Total
 
$
77,592


$
32


$
(113
)

$
77,511

 
We determine realized gains or losses on the sale of marketable securities on a specific identification method. We reflect these gains and losses as a component of investment income in the accompanying condensed consolidated statements of income (loss).
We recognized gross realized gains of $143 and $2,978 for the three months ended September 30, 2018, and 2017, respectively. These realized gains were offset by realized losses of $22 and $2,432 for the three months ended September 30, 2018, and 2017, respectively.
We recognized gross realized gains of $378 and $4,228 for the nine months ended September 30, 2018, and 2017, respectively. These realized gains were offset by realized losses of $350 and $3,755 for the nine months ended September 30, 2018, and 2017, respectively. 
The following table summarizes the estimated fair value of our investments in marketable debt securities, accounted for as available-for-sale securities and classified by the contractual maturity date of the securities as of September 30, 2018:
 
 
Maturities
Marketable Debt Securities:
 
Less than 1 Year
 
1-5 Years
 
5-10 Years
 
Greater than 10 Years
 
Total
 
 
 
 
 
 
 
 
 
 
 
Corporate bonds
 
$
19,017

 
$
13,820

 
$
199

 
$

 
$
33,036

Government securities - U.S.
 
831

 
12,224

 

 
501

 
13,556

Other fixed-income securities
 
51

 
9,296

 

 

 
9,347

Total
 
$
19,899

 
$
35,340

 
$
199

 
$
501

 
$
55,939


The Company has classified our investment in available-for-sale marketable securities as current assets in the condensed consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in our investment portfolio.